AUTHOREA
Log in Sign Up Browse Preprints

loading page

Sunitinib-induced thrombotic microangiopathy: a case report
  • +2
  • Mohammadreza ardalan,
  • Amirreza Khalaji,
  • Sepideh Zonuni Vahed,
  • Mohammadreza Moslemi,
  • Alireza Mirghaffari
Mohammadreza ardalan
Tabriz University of Medical Sciences

Corresponding Author:ardalan34@yahoo.com

Author Profile
Amirreza Khalaji
Tabriz University of Medical Sciences
Author Profile
Sepideh Zonuni Vahed
Tabriz University of Medical Sciences
Author Profile
Mohammadreza Moslemi
Tabriz University of Medical Sciences Faculty of Medicine
Author Profile
Alireza Mirghaffari
Tabriz University of Medical Sciences
Author Profile

Abstract

Sunitinib-induced thrombotic microangiopathy (TMA) is a secondary TMA caused by Sunitinib.Despite the extensive use of the drug ,little is known about this complication of Sunitinib. In this study, we reported a 63 years old male with Sunitinib induced TMA treated for metastatic renal cell carcinoma.

Peer review status:IN REVISION

27 Mar 2022Submitted to Clinical Case Reports
Show details
Hide details
16 May 2022Submission Checks Completed
16 May 2022Assigned to Editor
19 May 2022Reviewer(s) Assigned
03 Jun 2022Review(s) Completed, Editorial Evaluation Pending
08 Jun 2022Editorial Decision: Revise Minor
02 Aug 20221st Revision Received
22 Aug 2022Submission Checks Completed
22 Aug 2022Assigned to Editor
22 Aug 2022Review(s) Completed, Editorial Evaluation Pending
24 Aug 2022Reviewer(s) Assigned
01 Sep 2022Editorial Decision: Revise Minor
23 Jan 20232nd Revision Received
24 Jan 2023Submission Checks Completed
24 Jan 2023Assigned to Editor
24 Jan 2023Review(s) Completed, Editorial Evaluation Pending
08 Feb 2023Editorial Decision: Revise Minor